Cardiovascular disease incidence rates: a study using routinely collected health data.
Journal article
Ramroth J. et al, (2023), Cardiooncology, 9
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.
Journal article
Taylor C. et al, (2023), BMJ, 381
Erratum: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC).
Journal article
(2023), Eur Heart J Cardiovasc Imaging, 24
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Journal article
Geurts YM. et al, (2023), JAMA Oncol, 9, 481 - 489
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Journal article
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol)
Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
Journal article
Bates JE. et al, (2023), International Journal of Radiation Oncology Biology Physics
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Journal article
Houlihan OA. et al, (2022), Clin Transl Oncol
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Journal article
Lyon AR. et al, (2022), Eur Heart J Cardiovasc Imaging
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Journal article
Follows GA. et al, (2022), Br J Haematol, 197, 558 - 572
Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma
Conference paper
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S257 - S257
Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans
Conference paper
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S253 - S255
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Journal article
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Journal article
Jones DA. et al, (2022), Blood Adv, 6, 909 - 919
Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.
Journal article
Way A. et al, (2022), Int J Part Ther, 8, 76 - 81
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Journal article
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland
Conference paper
Houlihan O. et al, (2021), RADIOTHERAPY AND ONCOLOGY, 161, S900 - S901
Limited-stage diffuse large B-cell lymphoma: current management and challenges.
Journal article
Zhang X-Y. et al, (2021), Br J Haematol
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.
Journal article
Ntentas G. et al, (2020), Radiother Oncol, 153, 155 - 162